According to these findings, Fallerini et al. detected the presence of TLR7 missense variants in ≈2% of male patients with severe COVID-19, also demonstrating that these variants negatively impact on TLR7 downstream signaling and IFN-related gene expression [55]. The gene discussed is TLR7; the disease is COVID-19.